These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 26957571)

  • 21. New antigenic targets in type 1 diabetes.
    Wenzlau JM; Hutton JC; Davidson HW
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):315-20. PubMed ID: 18594270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta blocker.
    Davenport RJ
    Sci Aging Knowledge Environ; 2005 Mar; 2005(12):nf22. PubMed ID: 15788791
    [No Abstract]   [Full Text] [Related]  

  • 23. Association between FTO, MC4R, SLC30A8, and KCNQ1 gene variants and type 2 diabetes in Saudi population.
    Bazzi MD; Nasr FA; Alanazi MS; Alamri A; Turjoman AA; Moustafa AS; Alfadda AA; Pathan AA; Parine NR
    Genet Mol Res; 2014 Dec; 13(4):10194-203. PubMed ID: 25501231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mice lacking Ca(v)2.3 (alpha1E) calcium channel exhibit hyperglycemia.
    Matsuda Y; Saegusa H; Zong S; Noda T; Tanabe T
    Biochem Biophys Res Commun; 2001 Dec; 289(4):791-5. PubMed ID: 11735114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lens fluorescence in relation to glucose tolerance and genetic predisposition to type 2 diabetes mellitus in a population-based study.
    Koefoed Theil P; Kessel L; Hansen T; Lund-Andersen H; Pedersen O; Larsen M
    Curr Eye Res; 2006 Sep; 31(9):733-8. PubMed ID: 16966146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Thrifty Phenotype hypothesis: how does it look after 5 years?
    Hales CN; Desai M; Ozanne SE
    Diabet Med; 1997 Mar; 14(3):189-95. PubMed ID: 9088766
    [No Abstract]   [Full Text] [Related]  

  • 27. Can molecular genetics help in the clinic?
    Hattersley A
    Diabet Med; 1999 Sep; 16(9):788-91. PubMed ID: 10510959
    [No Abstract]   [Full Text] [Related]  

  • 28. A novel -192c/g mutation in the proximal P2 promoter of the hepatocyte nuclear factor-4 alpha gene (HNF4A) associates with late-onset diabetes.
    Ek J; Hansen SP; Lajer M; Nicot C; Boesgaard TW; Pruhova S; Johansen A; Albrechtsen A; Yderstraede K; Lauenborg J; Parrizas M; Boj SF; Jørgensen T; Borch-Johnsen K; Damm P; Ferrer J; Lebl J; Pedersen O; Hansen T
    Diabetes; 2006 Jun; 55(6):1869-73. PubMed ID: 16731855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus.
    Froguel P; Vaxillaire M; Sun F; Velho G; Zouali H; Butel MO; Lesage S; Vionnet N; Clément K; Fougerousse F
    Nature; 1992 Mar; 356(6365):162-4. PubMed ID: 1545870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Know when you need insulin.
    Johns Hopkins Med Lett Health After 50; 2005 May; 17(3):1-2. PubMed ID: 15841550
    [No Abstract]   [Full Text] [Related]  

  • 31. Self monitoring of blood glucose in type 2 diabetes.
    Heller SR
    BMJ; 2007 Jul; 335(7611):105-6. PubMed ID: 17641302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. American Diabetes Association. Resource guide 2005. Blood glucose meters and data management system.
    Diabetes Forecast; 2005 Jan; 58(1):RG36-46, RG49-54. PubMed ID: 15714618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.
    Froguel P; Zouali H; Vionnet N; Velho G; Vaxillaire M; Sun F; Lesage S; Stoffel M; Takeda J; Passa P
    N Engl J Med; 1993 Mar; 328(10):697-702. PubMed ID: 8433729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. beta Cell autoimmunity in a child with M.O.D.Y. (Maturity Onset Diabetes in the Young).
    Ortega-Rodriguez E; Levy-Marchal C; Guillermine S; Polak M
    Diabetes Metab; 2001 Feb; 27(1):59-61. PubMed ID: 11240447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis.
    Hollands GJ; French DP; Griffin SJ; Prevost AT; Sutton S; King S; Marteau TM
    BMJ; 2016 Mar; 352():i1102. PubMed ID: 26979548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human DNA Mutations and their Impact on Genetic Disorders.
    Samir S
    Recent Pat Biotechnol; 2024; 18(4):288-315. PubMed ID: 37936448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting human disease mutations and identifying drug targets from mouse gene knockout phenotyping campaigns.
    Brommage R; Powell DR; Vogel P
    Dis Model Mech; 2019 May; 12(5):. PubMed ID: 31064765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is Enhancement the Price of Prevention in Human Gene Editing?
    Juengst ET; Henderson GE; Walker RL; Conley JM; MacKay D; Meagher KM; Saylor K; Waltz M; Kuczynski KJ; Cadigan RJ
    CRISPR J; 2018 Dec; 1(6):351-354. PubMed ID: 31021238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating the relationship between lesion burden and aging among the skeletons of an 18th-19th century London cemetery using osteological and radiological analysis.
    van Schaik K; Eisenberg R; Bekvalac J; Rühli F
    PLoS One; 2018; 13(4):e0196448. PubMed ID: 29698453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Informing Prevention and Intervention Policy Using Genetic Studies of Resistance.
    Maher BS; Latendresse S; Vanyukov MM
    Prev Sci; 2018 Jan; 19(1):49-57. PubMed ID: 27943075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.